An Abiding Atrocity: Immune System Dysfunction and Cancer via SV40 Enhancer

Executive Summary

• Debate is raging between independent scientists who detected DNA contamination in the mRNA products, and the pharmaceutical industry and their representatives, who attempted to hide the contamination;
• A recent article provides evidence that DNA contamination, specifically the SV40 enhancer gene sequence detected in Pfizer’s commercial product, targets an immune system process called somatic hypermutation (SHM);
• SHM allows antibodies to change in order to target specific antigens (eg viruses), creating antibody diversity, whilst preventing the mutations that result in cancer;
• SV40 enhancer, a component of the SV40 virus, present as a contaminant in the Pfizer injection, appears to activate SHM in a manner that causes cancers;
• SV40 enhancer uses an enzyme required for SHM, to mutate an antigen found in the SV40 virus, causing the antigen to become carcinogenic, which is thought to be the mechanism for SV40 causing cancers;
• Whilst this specific tumour antigen is not present in Pfizer’s product, researchers hypothesise that the SV40 enhancer may target SHM in the presence of other antigens, leading to the generation of cancer;
• The evidence is sufficient to warrant withdrawal of the products until safety can be properly assessed;
• The company responsible for this contamination is purchasing cancer drug development companies as the regulators and safety monitors they sponsor deny there is a problem.

The Scientific Process vs. Professional “Debunking”

Some New Zealand experts have implied that the SV40 promoter and enhancer sequences detected in Pfizer and Moderna’s mRNA products can be ignored, following similar lines of dismissal as Australia’s Therapeutic Goods Administration (TGA).  A recent TGA media release, intended as a “debunk” of the science, has been described by Russell Broadbent MP as “wholly unreliable and misleading on at least 14 points“.

Despite their claims of authority on the matter, the TGA, and relevant government departments, have provided zero evidence to demonstrate why the detected contamination will not produce dire adverse health outcomes as outlined in the Science Summary.  Their media release has been extensively refuted by independent scientists sounding the alarm, in collaboration with investigative journalist Rebekah Barnett.

Representatives employed to protect the reputation of profitable “vaccines” under the false guise of “monitoring safety” have also entered into unbalanced debate on social media.  Anonymous x.com contributor Jikkyleaks has the aptitude to excoriate Helen Petousis-Harris with basic scientific facts, rebuked in return with accusations of “conspiracy theory”, “anti-vax” and “fallacies” rather than any exchange of information or data.

Serious Researchers Get to Work

Dr Jessica Rose is an immunologist, molecular and computational biologist, and biochemist uncovering evidence of harm via the vaccine adverse events reporting system (VAERS). Kevin McKernan is a geneticist who led research and development at the Human Genome Project at Massachusetts Institute of Technology, before co-founding his own medicinal genomics research company. Their investigations, alongside teams of collaborating independent scientists, are central to exposing the crimes taking place under the guise of public health.

Recently McKernan and Rose have each written separately about a preprint, The SV40 virus enhancer functions as a somatic hypermutation-targeting element with potential oncogenic activity, suggesting relevance of this research to the detection of SV40 enhancer in vials of Pfizer-BioNTech’s covid injectable product. McKernan’s summation of the preprint asks What’s a little Somatic Hyper Mutation-targeting element amongst friends? whilst Rose’s summation asks Is the generation of antibody diversity on the line?

Pfizer-BioNTech deliberately concealed their insertion of SV40 promoter and enhancer gene sequences from regulators. Learn more at our recent article Pfizer Crimes and the Complicity of “Independent” Representatives. This act of concealment alone, should warrant the immediate cessation of the approval of these products, and criminal charges.  As if predicting a looming market, Pfizer has since spent billions of dollars on the purchase of cancer drug development companies including Seagen and Trillium Therapeutics.

Warning: Science Ahead!

The crux of the science in this latest research relates to physiology of a healthy immune system resulting in an efficient response to invading organisms. Activation induced deaminase (AID) is an enzyme which causes somatic hypermutation (SHM). SHM is the mutation of immunoglobulin genes that enables them to change so as to match an attack against many different specific invaders. This ability to “clear a plethora of different foreign antigens” is known as antibody diversity.

Because gene mutations have the potential to cause disease and cancer, AID tightly controls and regulates SHM to prevent unwanted outcomes.  Changes only occur in domains on the antibody gene that are needed for an effective response to a specific antigen, whilst avoiding unwanted effects such as malignancies. Learn the mechanisms of this complicated process at AID and Somatic Hypermutation. Dr Rose’s article also explains it in some detail, including a useful video and infographics.

SV40 is a simian virus known to induce cancer in animal models.  Between 1955-1963 the Salk Polio vaccine was contaminated with SV40.  As reported here, by 1999 SV40 was being detected in a range of human cancers.

SV40 is most commonly associated with mesotheliomas, brain tumours, bone tumours and lymphomas. The SHM research demonstrates evidence that SV40 enhancer uses the AID enzyme specifically to mutate an antigen called Simian Virus Large Tumour antigen, abbreviated to SV40 T-Antigen. This mutation is thought to be the mechanism involved in SV40 generating human cancers.

Although SV40 T-Antigen is not present with the SV40 enhancer in Pfizer’s product, the authors provide evidence that mutations may occur via the SHM pathway in other cells, resulting in oncogenesis (cancer generation). They show that the presence of other viral infections can increase the rate of SHM.

Cause for Concern

Whilst these mechanisms for causing cancer remain hypothetical, there are genuine reasons for concern, for the seemingly perverse moves being made by Pfizer towards cancer drug development, and for the increasing demand for investigations into the risks to public health being made across the world from Australia to Slovakia. Dr Rose lists the following five concerns:

• Altered Antibody Affinity and Specificity: SV40’s potential to target AID could lead to aberrant mutations in immunoglobulin genes, resulting in altered antibody affinity and specificity. This might impact the effectiveness of the immune response.
• Increased Oncogenic Activity: The SV40 virus enhancer’s ability to target AID could introduce oncogenic mutations, potentially contributing to tumorigenesis. This is supported by the observation that SV40 is associated with several human cancers [as above].
• Error-Prone Repair Mechanisms: The introduction of SV40 could activate error-prone repair mechanisms, leading to an increased frequency of insertions, deletions, and point mutations in the vicinity of DNA breaks. This might result in the creation of novel oncogenic fusion genes or the disruption of tumor suppressor genes.
• Aberrant Expression of APOBEC Enzymes: SV40’s interaction with SHM elements could lead to aberrant expression and targeting of APOBEC cytidine deaminase family enzymes, which are known to induce mutations in viral genomes. This might result in the creation of novel oncogenic mutations or the selection of pre-existing mutations.
• Disruption of Normal SHM Process: The introduction of SV40 could disrupt the normal SHM process, potentially leading to impaired antibody diversification and reduced immune responses.

Takeaway: The Jabs Can Cause Cancer in Multiple Ways

NZDSOS have written an Open Letter to New Zealand officials alerting them to the concerns about DNA contamination in the products and links to cancer as outlined by Australian MP Russell Broadbent to Australian authorities. No response has been received by either ourselves or Mr Broadbent. What is stopping our authorities from responding to these alarming concerns?

Contrary to the claims of ‘scientific consensus’ on the alleged irrelevance of DNA contamination by industry representatives such as Helen Petousis Harris, eminently qualified doctors and scientists are sounding alarm bells. The World Council for Health Expert Hearing on DNA Contamination remains a relevant analysis. More recently the Stone Summit provided detail of multiple concerns relating to these products, not least of all the changing patterns in rising cancer rates presented by UK consultant surgeon James Royle.

On 19 October 2024 at the Back to Basics Summit on Family, Food and Health Care in Massachusetts, Kevin McKernan presented on the DNA and SV40 contamination found in vials of mRNA products, evidence for intentional deception, and evidence that the gene sequences are active in human tumours causing rapid and atypical cancers. He was especially alarmed that the SV40 sequence seemed to have multiplied in the body far beyond the amounts contained in the original injection doses. 

This is all frightening enough, but not half as scary as the ongoing insolent silence of authorities.  DNA contamination, including SV40, must not be dismissed without appropriate investigation.  Until that happens the products’ approval and use must be withdrawn.